Log In or Create Account

CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Guidelines
Contact

Advanced Search

CME Courses
CME Webinars
Dialogues
Topics In Antiviral Medicine
HIV Drug Resistance
Fellow Resources
About

Rebecca Abelman, MD

Rebecca Abelman, MD

Assistant Professor, Medicine

University of California San Francisco

San Francisco, CA

131 Steuart St, Suite 500, San Francisco, CA 94105

Phone: (415) 544-9400 | info@iasusa.org

Home
Activities
Resources
About
Contact
Login
Careers
Donate
Website Policies

© 2026 International Antiviral Society–USA. All Rights Reserved.

CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Guidelines
Contact
CME Courses
CME Webinars
Dialogues
Topics In Antiviral Medicine
HIV Drug Resistance
Fellow Resources
About

Practice Question of the Week

August 31, 2026: Management Strategies for Co-occurring Mpox and HIV

A 34-year-old man with untreated HIV (CD4+ count, 38 cells/µL) is diagnosed with mpox. Which of the following management strategies is most appropriate?
- A. Administer the Jynneos vaccine in a series of 2 doses 28 days apart
- B. Initiate tecovirimat 600 mg orally twice daily with a high-fat meal and treat for 14 days
- C. Delay antiretroviral therapy (ART) initiation until mpox lesions resolve
- D. Initiate ART while treating mpox and monitor closely for severe disease

View the On-Demand Webinar

View Archived Questions